To the central content area :::

TPEx

Listed Companies

ECO-Fin
:::
:::Listed Companies > Listed Companies Info. > Emerging Stock Board Companies > Listed Company Profile

ESM Companies

For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
6549 TaiwanJ
中文
Basic information
Chairman President Spokesperson Telephone Address ESM Registration Date
Ying Chu Shih Rich Yuan Rich Yuan 03-6587721 Rm.4,3F, No.6-1, Sec. 2, Shengyi Rd.,Zhubei City, Hsinchu County 302, Taiwan 2015/10/21
Industry
category
Key businesses
Biotechnology and Medical Care TaiwanJ is a specialty pharmaceutical company dedicated to the development and commercialization of first-in-class small molecules as TLR4 antagonists. The Company's drug development strategy is to reduce time-to-market, lower clinical risks, and minimize development costs by re-profiling approved drugs. In addition, the company is developing a rich pipeline of novel chemical entities (NCEs) for therapy to address chronic liver disease, inflammatory bowel disease, and rheumatoid arthritis, as well as organ damage to the kidney and the lung. Specific diseases targeted include liver inflammation, liver fibrosis, NASH, NALFD, and autoimmune diseases including rheumatoid arthritis and Crohn’s Disease. TaiwanJ seeks product development collaborations and strategic alliances to develop its pipeline of products into the market.
 
Market info
Latest trading info Historic trading info
 
Financial data
Cash flows statement Item
Amount(NTD, in thousands)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Consolidated/Individual
balance sheet
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Consolidated/Individual
profit and loss
statement
Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 Investors may find more detailed information on the company by visiting the Market Observation Post System.。
 The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.